puc-header

Degradation of SARS-CoV-2 Receptor ACE2 by Tobacco Carcinogens

29 Pages Posted: 31 Jul 2020 Publication Status: Review Complete

See all articles by Gui-Zhen Wang

Gui-Zhen Wang

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology

Qun Zhao

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Fan Liang

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Chen Zhang

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Hui Zhang

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Jun Wang

Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Zhen-Yin Chen

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Ran Wu

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Hong Yu

School of Chinese Materia Medica, Beijing University of Chinese Medicine

Bei-Bei Sun

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Ruie Feng

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Kai-Feng Xu

Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Guang-Biao Zhou

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology; Peking University - State Key Laboratory of Membrane Biology

More...

Abstract

An unexpected observation among the COVID-19 pandemic is that smokers constituted only 1.4-18.5% of hospitalized adults, calling for an urgent investigation to determine the role of smoking in SARS-CoV-2 infection. Here, we show that cigarette smoke extract (CSE) and carcinogen benzo(a)pyrene (BaP) increase ACE2 mRNA but trigger ACE2 protein catabolism. BaP induces an aryl hydrocarbon receptor (AhR)-dependent upregulation of the ubiquitin E3 ligase Skp2 for ACE2 ubiquitination. ACE2 in lung tissues of non-smokers is higher than in smokers, consistent with the findings that tobacco carcinogens downregulate ACE2 in mice. Tobacco carcinogens inhibit SARS-CoV-2 Spike protein pseudovirions infection of the cells. These data indicate that recommendation of cessation of tobacco smoking remains valid because it is the carcinogens that are responsible for ACE2 degradation.

Keywords: ACE2, SARS-CoV-2, tobacco smoke, carcinogens, ubiquitination, degradation

Suggested Citation

Wang, Gui-Zhen and Zhao, Qun and Liang, Fan and Zhang, Chen and Zhang, Hui and Wang, Jun and Chen, Zhen-Yin and Wu, Ran and Yu, Hong and Sun, Bei-Bei and Feng, Ruie and Xu, Kai-Feng and Zhou, Guang-Biao, Degradation of SARS-CoV-2 Receptor ACE2 by Tobacco Carcinogens. Available at SSRN: https://ssrn.com/abstract=3664371 or http://dx.doi.org/10.2139/ssrn.3664371
This version of the paper has not been formally peer reviewed.

Gui-Zhen Wang

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology

Beijing, 100021
China

Qun Zhao

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Fan Liang

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Chen Zhang

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Hui Zhang

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Jun Wang

Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Zhen-Yin Chen

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ( email )

Ran Wu

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Hong Yu

School of Chinese Materia Medica, Beijing University of Chinese Medicine

Bei-Bei Sun

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ( email )

Ruie Feng

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences ( email )

Kai-Feng Xu

Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences ( email )

Guang-Biao Zhou (Contact Author)

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology ( email )

Beijing, 100021
China

Peking University - State Key Laboratory of Membrane Biology ( email )

Beijing, 100871
China